Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.

Abstract:

OBJECTIVE:The objective of this study was to analyse autoantibodies' titres modulation during belimumab treatment in 50 patients with systemic lupus erythematosus (SLE). METHODS:Sera were collected at belimumab start (T0) and every six months until the 24th month. Disease activity index (SLEDAI-2K) was analysed at every timepoint. High avidity anti-dsDNA was detected by radioimmunological method, anti-ENA, anti-cardiolipin antibodies (aCL), anti-β2 glycoprotein I (anti-β2GPI) were analysed by ELISA. RESULTS:Fifty patients with SLE (mean SLEDAI-2K: 7.18 ± :3), mean age of 39 ± 11 years and mean follow-up of 13 ± 7.8 years were enrolled. A significant decrease of anti-dsDNA and anti-β2GPI IgM titres was observed at all timepoints. IgG aCL titre showed significant decrease only at T18. Anti-dsDNA negativization was detected in 21%, anti-β2GPI IgG in 33% and aCL IgG in 30% of sera, mostly at T6. Anti-ribosomal showed a significant titre decrease at T6 and T12, with negative seroconversion at T18. Anti-Sm titre significantly dropped down at T6, then remained stable during the time. Significant correlations were found between anti-dsDNA and anti-ribosomal titre and between SLEDAI ratio (SLEDAI value/SLEDAI T0) and anti-ribosomal titre ratio (value/value T0). CONCLUSIONS:Belimumab treatment induced a significant reduction of SLE-specific autoantibodies titre and IgM anti-β2GPI. Anti-ribosomal titre decrease correlates with anti-dsDNA titre and disease activity improvement.

journal_name

Lupus

journal_title

Lupus

authors

Cavazzana I,Kumar R,Pozzari C,Ottaviani R,Fredi M,Piantoni S,Andreoli L,Tincani A,Franceschini F

doi

10.1177/0961203319860191

subject

Has Abstract

pub_date

2019-08-01 00:00:00

pages

1074-1081

issue

9

eissn

0961-2033

issn

1477-0962

journal_volume

28

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach.

    abstract::Systemic lupus erythematosus (SLE) is a multi-organ inflammatory disorder mainly affecting women and is associated with high cardiovascular morbidity and mortality. We tested the utility of a comprehensive cardiovascular magnetic resonance approach to assess myocardial involvement and to determine its relation to dise...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089401

    authors: Abdel-Aty H,Siegle N,Natusch A,Gromnica-Ihle E,Wassmuth R,Dietz R,Schulz-Menger J

    更新日期:2008-06-01 00:00:00

  • Superior mesenteric artery syndrome and intra-abdominal compartment syndrome in systemic lupus erythematosus.

    abstract::Gastrointestinal manifestations of systemic lupus erythematosus (SLE) are common, occurring in about 50% of cases. They are usually mild, in the form of mouth ulcers, nausea, heartburn and mild abdominal pain, but they can be severe in cases of gastrointestinal vasculitis. In this report we describe an unusual combina...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313517150

    authors: Bedaiwi M,Alkubeyyer MA,Al Arfaj AS

    更新日期:2014-02-01 00:00:00

  • Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients.

    abstract::The aim of this study is to determine prevalence, clinical significance of antiphospholipid antibodies (aPL) including anticardiolipin antibodies (aCL), anti-beta2GP1 and lupus anticoagulant (LA) in a cohort of 74 patients with primary Sjögren's syndrome (pSS) according to revised European criteria. aPL were found in ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1006oa

    authors: Fauchais AL,Lambert M,Launay D,Michon-Pasturel U,Queyrel V,Nguyen N,Hebbar M,Hachulla E,Devulder B,Hatron PY

    更新日期:2004-01-01 00:00:00

  • Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies. Recently, a specific highly activated T helper cell subset, follicular helper T (Tfh) cell, has emerged as a key immunoregulator of germinal center (GC) formation and high-affinity antibody productio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314567750

    authors: Zhang X,Lindwall E,Gauthier C,Lyman J,Spencer N,Alarakhia A,Fraser A,Ing S,Chen M,Webb-Detiege T,Zakem J,Davis W,Choi YS,Quinet R

    更新日期:2015-08-01 00:00:00

  • Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies.

    abstract::Criteria of organ-specific autoimmunity are fulfilled in a subset of patients with myocarditis/dilated cardiomyopathy (DCM). In particular, circulating heart-reactive autoantibodies are found in patients and symptom-free relatives. These autoantibodies are directed against multiple antigens, some of which are expresse...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2193oa

    authors: Caforio AL,Daliento L,Angelini A,Bottaro S,Vinci A,Dequal G,Tona F,Iliceto S,Thiene G,McKenna WJ

    更新日期:2005-01-01 00:00:00

  • Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.

    abstract::To determine whether killer cell immunologlobulin-like receptor (KIR) genotypes are associated with vasculitis, vascular arterial events or anticardiolipin (aCL) antibodies in patients with lupus. A total of 304 patients followed prospectively at the University of Toronto Lupus Clinic were assessed for the occurrence ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089443

    authors: Toloza S,Pellett F,Chandran V,Ibanez D,Urowitz M,Gladman D

    更新日期:2008-09-01 00:00:00

  • Sulpha allergy in lupus patients: a clinical perspective.

    abstract::Systemic lupus erythematosus is a chronic, relapsing autoimmune disease that can affect multiple organ systems. An increased prevalence of drug allergy has been reported in lupus patients compared with the general population. Using a cohort of 417 lupus patients, we found a history of sulpha allergy in 27.3% of patien...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086640

    authors: Jeffries M,Bruner G,Glenn S,Sadanandan P,Carson CW,Harley JB,Sawalha AH

    更新日期:2008-03-01 00:00:00

  • Speckle tracking echocardiography for the evaluation of left ventricular function in children with systemic lupus erythematosus.

    abstract:BACKGROUND:Many studies in adult patients with systemic lupus erythematosus (SLE) have demonstrated that myocardial dysfunction was significantly associated with enhanced disease activity. However, similar studies in paediatric patients with SLE are limited. The aim of this study was to evaluate the role of speckle tra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320942296

    authors: Emara M,Hafez MA,El-Bendary A,Razaky OE

    更新日期:2020-10-01 00:00:00

  • The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome.

    abstract::This study was designed to investigate whether Foxp3( +) regulatory T (Treg) cells play a role in the histopathologic changes of primary Sjögren's Syndrome (pSS) and to evaluate other factors possibly associated with Foxp3(+) Treg cells in pSS patients. The number of FoxP3-expressing T cells in peripheral blood (PB) o...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309348234

    authors: Sarigul M,Yazisiz V,Bassorgun CI,Ulker M,Avci AB,Erbasan F,Gelen T,Gorczynski RM,Terzioglu E

    更新日期:2010-02-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • Cognitive dysfunction in SLE: development of a screening tool.

    abstract:BACKGROUND:Cognitive dysfunction (CD) is among the most common neuropsychiatric manifestations of systemic lupus erythematosus (SLE). There are two methods which have been used to detect CD in patients with SLE: traditional neuropsychological tests (NPT) and the Automated Neuropsychological Assessment Metrics (ANAM). B...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311405374

    authors: Adhikari T,Piatti A,Luggen M

    更新日期:2011-10-01 00:00:00

  • Lupus nephritis in Latin American patients: 10-year results from a single medical center in Argentina.

    abstract:INTRODUCTION:Several studies have shown that Hispanic patients generally experience a worse renal prognosis than non-Hispanic white patients with lupus. To date, there is no report on American College of Rheumatology (ACR) renal response criteria (ACR-RRC) in patients from Latin America. OBJECTIVE:To evaluate treatmen...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600537

    authors: Vinicki JP,Paniego FM,De Rosa G,Dubinsky D,Laborde HA,Marini A,Nasswetter G

    更新日期:2016-02-01 00:00:00

  • Entheseal involvement in systemic lupus erythematosus: are we missing something?

    abstract::Background Musculoskeletal involvement is extremely common in patients with systemic lupus erythematosus (SLE). Continuing the research initiated in patients with inflammatory arthritis, recent studies have shown the potential role of musculoskeletal ultrasound (MSUS) in the evaluation of clinical and subclinical lupu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316662723

    authors: Di Matteo A,Satulu I,Di Carlo M,Lato V,Filippucci E,Grassi W

    更新日期:2017-03-01 00:00:00

  • Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus.

    abstract::Chronic intestinal pseudo-obstruction (CIPO) is a rare clinical syndrome of ineffective intestinal motility characterised by clinical and radiological evidence of intestinal obstruction with no identifiable mechanical lesion. CIPO can either be idiopathic or secondary to a systemic disease, like systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313492873

    authors: Khairullah S,Jasmin R,Yahya F,Cheah TE,Ng CT,Sockalingam S

    更新日期:2013-08-01 00:00:00

  • Uncommon cutaneous manifestations of lupus erythematosus.

    abstract::Cutaneous manifestations of lupus erythematosus (LE) are, usually, characteristic enough to permit an easy diagnosis. However, some patients may present less typical lesions, associated or not to the classic ones. Therefore, irrespectively of the variety of LE (acute, subacute and chronic), in absence of the typical b...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339700600207

    authors: Mascaro JM,Herrero C,Hausmann G

    更新日期:1997-01-01 00:00:00

  • The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review.

    abstract::Pericardial effusions causing pericardial tamponade are rare in patients with systemic lupus erythematosus (SLE). The goal of this study is to describe in detail the clinical and laboratory characteristics of a group of patients with pericardial effusions and pericardial tamponade secondary to SLE. We retrospectively ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308100659

    authors: Rosenbaum E,Krebs E,Cohen M,Tiliakos A,Derk CT

    更新日期:2009-06-01 00:00:00

  • Severe valvular heart disease in a patient with primary antiphospholipid syndrome.

    abstract::Valvular replacement was performed in a patient with primary antiphospholipid syndrome and severe mitral insufficiency. The valvular tissue presented thrombotic phenomena and fibrosis with minimum inflammatory component. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:

    authors: Alvarez-Blanco A,Egurbide-Arberas MV,Aguirre-Errasti C

    更新日期:1994-10-01 00:00:00

  • Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort.

    abstract::Objective Adherence to medication has a major impact on treatment control and success especially in chronic diseases but often remains unrecognized. Besides clinical, socioeconomic, disease-related and treatment-related parameters, general and personal health beliefs, as well as perception of health, can affect adhere...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318785245

    authors: Chehab G,Sauer GM,Richter JG,Brinks R,Willers R,Fischer-Betz R,Winkler-Rohlfing B,Schneider M

    更新日期:2018-09-01 00:00:00

  • Systemic lupus erythematosus patients in the low-latitude plateau of China: altitudinal influences.

    abstract::The current study was to investigate the features of hospitalized patients with systemic lupus erythematosus (SLE) at different altitudes. The correlation between SLE activity and altitudinal variations was also explored. Medical records of 1029 patients were retrospectively reviewed. Activity of SLE in each organ sys...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314544186

    authors: Qian G,Ran X,Zhou CX,Deng DQ,Zhang PL,Guo Y,Luo JH,Zhou XH,Xie H,Cai M

    更新日期:2014-12-01 00:00:00

  • Lupus nephritis in Croatian children: clinicopathologic findings and outcome.

    abstract::We report clinical and histopathological features, treatment and outcome of 37 Croatian children with biopsy-proven lupus nephritis seen over a 30-year period. The mean age at lupus nephritis presentation was 12.11 ± 2.59 years (range 4.66-17.0). The most frequent histopathological finding was class IV (37.8%), follow...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314563133

    authors: Batinić D,Milošević D,Čorić M,Topalović-Grković M,Jelušić M,Turudić D

    更新日期:2015-03-01 00:00:00

  • Impairment of quality of life in patients with antiphospholipid syndrome.

    abstract:OBJECTIVES:Health-related quality of life (HRQoL) has not been fully explored in antiphospholipid syndrome (APS); therefore, we compared HRQoL between APS patients and the general population and assessed the impact of thromboembolic history. METHODS:HRQoL was measured in a multicentre cohort study by the Medical Outco...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315580871

    authors: Zuily S,Rat AC,Regnault V,Kaminsky P,Mismetti P,Ninet J,Baillet N,Magy-Bertrand N,Pasquali JL,Lambert M,Pasquier E,Lorcerie B,Lecompte T,Guillemin F,Wahl D,TAC(I)T investigators.

    更新日期:2015-10-01 00:00:00

  • Autoimmune thyroid disorders in SLE in Singapore.

    abstract::One hundred and twenty-nine patients with systemic lupus erythematosus were screened for thyroid function tests. Of these, 8.9% had hyperthyroidism and 3.9% Hashimoto's thyroiditis. Euthyroid sick syndrome was present in 47.8% of patients. There was a high prevalence of antimicrosomal and antithyroglobulin antibodies ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200109

    authors: Boey ML,Fong PH,Lee JS,Ng WY,Thai AC

    更新日期:1993-02-01 00:00:00

  • The SLICC/ACR damage index: progress report and experience in the field.

    abstract::The SLICC/ACR damage index for SLE was developed to assess accumulated damage since the onset of the disease. The damage includes non-reversible changes in organs and systems affected by the disease process itself, its therapy, or inter-current illness. This paper describes the development of the damage index, its val...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399680411335

    authors: Gladman DD,Urowitz MB

    更新日期:1999-01-01 00:00:00

  • Infections in infancy and the presence of antinuclear antibodies in adult life.

    abstract::There has been limited success defining environmental factors important to the development of connective tissue diseases such as systemic lupus erythematosus (SLE). Recent work has suggested that the perinatal environment may be important. To investigate this we measured antinuclear antibodies (ANA) in a general popul...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2286oa

    authors: Edwards CJ,Syddall H,Goswami R,Goswami P,Dennison EM,Cooper C

    更新日期:2006-01-01 00:00:00

  • What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?

    abstract::Heart valve disease (HVD) is the most common cardiac manifestation in the antiphospholipid syndrome (APS). Valve lesions should be described according to the established definition. HVD is progressive despite anticoagulant/antiplatelet treatments. Around 4-6% of patients with HVD in APS will require valve replacement ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314534307

    authors: Amigo MC

    更新日期:2014-10-01 00:00:00

  • Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.

    abstract:OBJECTIVE:The feed-forward loop of type I interferons (IFNs) production and subsequent immunopathology of systemic lupus erythematosus (SLE) has been hypothesised to be disrupted with inhibition of IFNα or type I IFN receptor subunit 1 (IFNAR). This systematic review and meta-analysis present the treatment efficacy and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320959702

    authors: Koh JWH,Ng CH,Tay SH

    更新日期:2020-12-01 00:00:00

  • Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.

    abstract:INTRODUCTION:Anti-ganglioside antibodies (AGA) have been associated with several peripheral neuropathies, such as Miller-Fisher syndrome, Guillain-Barré syndrome and multifocal motor neuropathy. They have also been studied in patients with systemic lupus erythematosus (SLE), focusing on neuropsychiatric manifestations ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312436856

    authors: Labrador-Horrillo M,Martinez-Valle F,Gallardo E,Rojas-Garcia R,Ordi-Ros J,Vilardell M

    更新日期:2012-05-01 00:00:00

  • Eosinophilic enteritis in association with systemic lupus erythematosus.

    abstract::Eosinophilic gastroenteritis (EGE) is an uncommon disease and has rarely been reported in association with connective tissue diseases as systemic lupus erythematosus. We report a 36-year-old woman who developed recurrent episodes of abdominal pain, nausea, vomiting and melena. Complete blood counts showed elevated eos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308097573

    authors: Jaimes-Hernandez J,Aranda-Peirera P,Melendez-Mercado CI

    更新日期:2009-04-01 00:00:00

  • Cross-reactivity and pathogenicity of anti-DNA autoantibodies in systemic lupus erythematosus.

    abstract::Autoantibodies to DNA were discovered over 40 years ago following the discovery a few years earlier of the 'LE' cell phenomenon by Hargraves and colleagues in 1948. These investigators noted that, when leucocytes were incubated with serum from lupus patients, changes in the nucleus could be seen together with phagocyt...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu317oa

    authors: Mageed RA,Zack DJ

    更新日期:2002-01-01 00:00:00

  • The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.

    abstract:OBJECTIVES:The objective of this paper is to perform the cross-cultural validation of the French version of the LupusPRO, a disease-targeted patient-reported outcome measure, among systemic lupus erythematosus (SLE) patients in Canada. METHODS:The French version of the LupusPRO and the MOS SF-36 were administered; dem...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543921

    authors: Bourré-Tessier J,Clarke AE,Kosinski M,Mikolaitis-Preuss RA,Bernatsky S,Block JA,Jolly M

    更新日期:2014-12-01 00:00:00